Here are relevant reports on : biotechnology-reagent-market
-
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029
The global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cyclopentane Market by Function (Blowing Agent & Refrigerant, Solvent & Reagent), Application (Residential Refrigerators, Commercial Refrigerators, Insulated Containers, Insulating Construction Materials, Electrical), and Region - Global Forecast to 2030
The global cyclopentane market is projected to grow from USD 0.39 billion in 2025 to USD 0.52 billion by 2030, at a CAGR of 6.1% during the forecast period. Some of the leading players in this market include Haltermann Carless Group GmbH (Germany), Junyuan Petroleum Group (China), INEOS (UK), Zeon Corporation (Japan), and Puyang Zhongwei Fine Chemical Co., Ltd. (China).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
High-Resolution Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021
The global high-resolution melting analysis market is projected to grow at a CAGR of 3.1%. Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Slide Stainer Market by Product (Reagent (Stains, Probes, ABS), Equipment (Automated, Manual)), Technology (H&E, IHC, ISH, Cytology), Application (Disease Diagnosis (Cancer) Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2027
Slide stainer market growth is primed to transition from $4.3 billion in 2022 to $5.9 billion by 2027, showcasing a strong CAGR of 6.8%. The growth in this market is driven by the increasing diagnosis of cancer, infectious, and other chronic diseases, expanding patient base and improving healthcare infrastructure.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028
The global blood screening market, valued at US$2.3 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.4 billion by the end of the period. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030
The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$6.27 billion by the end of the period. The market's accelerated growth trajectory is primarily driven by increasing demand for precision dispensing in pharmaceutical manufacturing, diagnostics, and medical device production.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
